Please login to the form below
Zydus Cadila
This page shows the latest Zydus Cadila news and features for those working in and with pharma, biotech and healthcare.
Merck enters agreement with Hanmi for investigational NASH drug
Meanwhile, Zydus Cadila became the first pharma company in the world to win approval for a NASH drug, after scoring authorisation for its drug saroglitazar in India.
Latest news
-
Zydus Cadila scores first ever NASH approval, in India
Drug has already been approved for diabetes related conditions. Zydus Cadila has become the first pharma company in the world to win approval for a non-alcoholic steatohepatitis (NASH) drug, after ... According to Zydus, around 25% of the population in
-
Shire gives up on Momenta-partnered Humira biosimilar
Zydus Cadila and Torrent Pharma already sell Humira biosimilars in India.
-
Allergan buys two NASH drug developers in one day
Other candidates in clinical development include Bristol-Myers Squibb/Ambrx' BMS 986036, Horizon/Raptor Therapeutics' RP103, Zydus Cadila's saroglitazar (in phase III) and Gilead Sciences' simtuzumab (phase II).
-
FDA verdict on Amgen's Humira biosimilar due in September
At the end of last year, patients in India were the first to receive a Humira biosimilar launched by Indian company Zydus Cadila.
-
AbbVie's Humira wins ninth US approval
At the end of last year, patients in India were the first to receive a Humira biosimilar launched by Indian company Zydus Cadila.
More from news
Approximately 2 fully matching, plus 13 partially matching documents found.
Subscribe to our email news alerts
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Sanofi's frexalimab shows promise in relapsing forms of MS
- Amgen reports positive results for Otezla in psoriatic arthritis
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Seqera Labs and Genomics England partner to progress genomic research
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s RSV vaccine approved by FDA for older adults
No results were found
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
- Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
- Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...
